98136-86-8Relevant articles and documents
Process Optimization for the Large-Scale Preparation of (2 S,3 aR,7 aS)- tert-Butyl Hexahydro-2,5-methanopyrrolo[3,2- c]pyridine-1(4 H)-carboxylate, an Intermediate for Nicotinic Acetylcholine Receptor Agonists
Jarugu, Lokesh Babu,Reddy, China Anki,Chikkananjunda, Nanjundaswamy Kanikahalli,Krishnamoorthy, Suresh,Sarvanakumar, Pon,Sankar, Ulaganathan,Arunachalam, Pirama Nayagam,McDonald, Ivar M.,Olson, Richard E.,Rampulla, Richard,Mathur, Arvind,Gupta, Anuradha
, p. 1276 - 1281 (2018)
An optimized large-scale synthesis of (2S,3aR,7aS)-tert-butyl hexahydro-2,5-methanopyrrolo[3,2-c]pyridine-1(4H)-carboxylate (1A), an important intermediate for nicotinic acetylcholine receptor agonists, is described. The key feature of the synthesis involves three transformations in a one-pot process, including debenzylation and ring hydrogenation of two fused bicyclic rings. Multihundred gram quantities of 1A were prepared.
TETRACYCLIC INHIBITORS OF JANUS KINASES
-
Page/Page column 96, (2008/06/13)
The present invention provides compounds that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases and cancer.